跳至主要内容
临床试验/EUCTR2013-002561-19-AT
EUCTR2013-002561-19-AT进行中(未招募)1 期

A prospective, double blind, randomised, placebo controlled trial to evaluate the effect of a long term tokolysis with atosiban on the pregnancy outcome. A pilot study. - Long term tokolysis with atosiban

Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin0 个研究点目标入组 60 人开始时间: 2014年1月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • intact singleton pregnancy between 23+0 and 28+0 weeks gestation
  • intact membranes
  • cervical length = 15mm
  • immediate previous completion of standard tocolysis with atosiban for 48 hours
  • Able to communicate well with the investigator, to understand and comply with the requirements of the study
  • Signed the written informed consent
  • women over 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • rupture of membranes
  • Amnion infection syndrome, fever (>38°C)
  • vaginal bleeding with intensity of menstruation or above
  • placenta praevia
  • polyhydramnion
  • congenital malformations, deformations and chromosomal abnormalities
  • preexistant Diabetes Typ I or II
  • multiple pregnancies
  • Prolaps of membranes till the external cervical os.

研究者

发起方
Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin

相似试验